OA11729A - Oral vaccine against diarrhea. - Google Patents
Oral vaccine against diarrhea. Download PDFInfo
- Publication number
- OA11729A OA11729A OA1200100151A OA1200100151A OA11729A OA 11729 A OA11729 A OA 11729A OA 1200100151 A OA1200100151 A OA 1200100151A OA 1200100151 A OA1200100151 A OA 1200100151A OA 11729 A OA11729 A OA 11729A
- Authority
- OA
- OAPI
- Prior art keywords
- cfa
- vaccine
- etec
- ctb
- amount
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9804415A SE515285C2 (sv) | 1998-12-18 | 1998-12-18 | Oralt vaccin mot diarré |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA11729A true OA11729A (en) | 2005-05-12 |
Family
ID=20413742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200100151A OA11729A (en) | 1998-12-18 | 1999-12-09 | Oral vaccine against diarrhea. |
Country Status (25)
| Country | Link |
|---|---|
| EP (2) | EP1140159A1 (cs) |
| JP (1) | JP2002532562A (cs) |
| KR (1) | KR20010101233A (cs) |
| CN (1) | CN1330552A (cs) |
| AP (1) | AP1426A (cs) |
| AU (1) | AU778223B2 (cs) |
| BR (1) | BR9916278A (cs) |
| CA (1) | CA2352309A1 (cs) |
| CZ (1) | CZ20011947A3 (cs) |
| EE (1) | EE200100309A (cs) |
| HR (1) | HRP20010433A2 (cs) |
| HU (1) | HUP0104552A3 (cs) |
| ID (1) | ID29857A (cs) |
| IL (1) | IL143808A0 (cs) |
| IS (1) | IS5967A (cs) |
| MX (1) | MXPA01006200A (cs) |
| NO (1) | NO20012889D0 (cs) |
| NZ (1) | NZ527559A (cs) |
| OA (1) | OA11729A (cs) |
| PL (1) | PL198438B1 (cs) |
| SE (1) | SE515285C2 (cs) |
| TR (1) | TR200101542T2 (cs) |
| WO (1) | WO2000037106A1 (cs) |
| YU (1) | YU41701A (cs) |
| ZA (1) | ZA200104362B (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7527802B2 (en) * | 2001-02-13 | 2009-05-05 | The United States Of America As Represented By The Secretary Of The Army | Vaccine for transcutaneous immunization |
| GB0121998D0 (en) | 2001-09-11 | 2001-10-31 | Acambis Res Ltd | Attenuated bacteria useful in vaccines |
| EP1543836A1 (en) * | 2003-12-17 | 2005-06-22 | Berna Biotech AG | Recombinant Vibrio cholerae strain and vaccine comprising said strain |
| WO2008133926A1 (en) * | 2007-04-24 | 2008-11-06 | Celldex Therapeutics, Inc: | V. cholerae hyperexpressing recombinant cholera toxin b subunit showing dual immunogenicity |
| BR112014005601B1 (pt) * | 2011-09-12 | 2020-09-29 | Scandinavian Biopharma Holding Ab | Vacina oral para a imunização contra a diarréia induzida pela etec |
| BR112014005596B1 (pt) * | 2011-09-12 | 2020-03-24 | Scandinavian Biopharma Holding Ab | Método para aumentar a apresentação de antígeno cs6 de etec na superfície da célula, método para a fabricação de uma vacina de célula inteira morta, e, vacina para a imunização contra etec que expressa cs6 |
| RU2753410C2 (ru) * | 2020-01-14 | 2021-08-16 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина" | Способ получения анатоксин-вакцины против эшерихиоза животных |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9100556D0 (sv) * | 1991-02-26 | 1991-02-26 | Holmgren Jan | Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans |
-
1998
- 1998-12-18 SE SE9804415A patent/SE515285C2/sv not_active IP Right Cessation
-
1999
- 1999-12-09 BR BR9916278-4A patent/BR9916278A/pt not_active Application Discontinuation
- 1999-12-09 TR TR2001/01542T patent/TR200101542T2/xx unknown
- 1999-12-09 EP EP99964847A patent/EP1140159A1/en not_active Withdrawn
- 1999-12-09 EE EEP200100309A patent/EE200100309A/xx unknown
- 1999-12-09 IL IL14380899A patent/IL143808A0/xx not_active IP Right Cessation
- 1999-12-09 WO PCT/SE1999/002306 patent/WO2000037106A1/en not_active Application Discontinuation
- 1999-12-09 JP JP2000589216A patent/JP2002532562A/ja not_active Withdrawn
- 1999-12-09 AU AU30889/00A patent/AU778223B2/en not_active Ceased
- 1999-12-09 OA OA1200100151A patent/OA11729A/en unknown
- 1999-12-09 MX MXPA01006200A patent/MXPA01006200A/es not_active IP Right Cessation
- 1999-12-09 KR KR1020017007484A patent/KR20010101233A/ko not_active Application Discontinuation
- 1999-12-09 HU HU0104552A patent/HUP0104552A3/hu unknown
- 1999-12-09 ID IDW00200101304A patent/ID29857A/id unknown
- 1999-12-09 CZ CZ20011947A patent/CZ20011947A3/cs unknown
- 1999-12-09 EP EP04010662A patent/EP1444987A3/en not_active Withdrawn
- 1999-12-09 NZ NZ527559A patent/NZ527559A/en unknown
- 1999-12-09 CA CA002352309A patent/CA2352309A1/en not_active Abandoned
- 1999-12-09 PL PL348257A patent/PL198438B1/pl unknown
- 1999-12-09 AP APAP/P/2001/002174A patent/AP1426A/en active
- 1999-12-09 YU YU41701A patent/YU41701A/sh unknown
- 1999-12-09 CN CN99814553A patent/CN1330552A/zh active Pending
-
2001
- 2001-05-28 ZA ZA200104362A patent/ZA200104362B/en unknown
- 2001-06-08 HR HR20010433A patent/HRP20010433A2/hr not_active Application Discontinuation
- 2001-06-12 NO NO20012889A patent/NO20012889D0/no not_active Application Discontinuation
- 2001-06-13 IS IS5967A patent/IS5967A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000037106A1 (en) | 2000-06-29 |
| SE515285C2 (sv) | 2001-07-09 |
| NO20012889L (no) | 2001-06-12 |
| ID29857A (id) | 2001-10-18 |
| AU778223B2 (en) | 2004-11-25 |
| PL348257A1 (en) | 2002-05-20 |
| PL198438B1 (pl) | 2008-06-30 |
| HUP0104552A3 (en) | 2002-08-28 |
| EP1140159A1 (en) | 2001-10-10 |
| IS5967A (is) | 2001-06-13 |
| JP2002532562A (ja) | 2002-10-02 |
| CZ20011947A3 (cs) | 2001-12-12 |
| SE9804415D0 (sv) | 1998-12-18 |
| AU3088900A (en) | 2000-07-12 |
| NO20012889D0 (no) | 2001-06-12 |
| EP1444987A3 (en) | 2005-12-21 |
| AP1426A (en) | 2005-06-06 |
| TR200101542T2 (tr) | 2001-10-22 |
| MXPA01006200A (es) | 2002-04-17 |
| ZA200104362B (en) | 2002-01-14 |
| HUP0104552A2 (hu) | 2002-04-29 |
| IL143808A0 (en) | 2002-04-21 |
| EP1444987A2 (en) | 2004-08-11 |
| EE200100309A (et) | 2002-08-15 |
| NZ527559A (en) | 2005-01-28 |
| SE9804415L (sv) | 2000-06-19 |
| HRP20010433A2 (en) | 2002-06-30 |
| CN1330552A (zh) | 2002-01-09 |
| YU41701A (sh) | 2005-07-19 |
| KR20010101233A (ko) | 2001-11-14 |
| CA2352309A1 (en) | 2000-06-29 |
| BR9916278A (pt) | 2001-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Su-Arehawaratana et al. | Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand | |
| Black et al. | Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin | |
| Holmgren et al. | An oral B subunit: whole cell vaccine against cholera | |
| Taylor et al. | Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru | |
| Migasena et al. | Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults | |
| LEVINE et al. | Pediatric diarrhea: the challenge of prevention | |
| Girón et al. | Simultaneous expression of CFA/I and CS3 colonization factor antigens of enterotoxigenic Escherichia coli by ΔaroC, ΔaroD Salmonella typhi vaccine strain CVD 908 | |
| US6558678B1 (en) | Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans | |
| Wiedermann et al. | Double‐Blind, Randomized, Placebo Controlled Pilot Study Evaluating Efficacy and Reactogenicity of an Oral ETEC B‐Subunit‐Inactivated Whole Cell Vaccine against Travelers’ Diarrhea (Preliminary Report) | |
| Ranallo et al. | Construction and characterization of bivalent Shigella flexneri 2a vaccine strains SC608 (pCFAI) and SC608 (pCFAI/LTB) that express antigens from enterotoxigenic Escherichia coli | |
| AU778223B2 (en) | Oral vaccine against diarrhea | |
| Taylor et al. | Expanded safety and immunogenicity of a bivalent, oral, attenuated cholera vaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama | |
| Holmgren et al. | Development of oral vaccines against cholera and enterotoxinogenic Escherichia coli diarrhea | |
| Holmgren et al. | Oral immunization against cholera | |
| Barry et al. | Multivalent Shigella Enterotoxigenic Escherichia coli Vaccine | |
| CN111936162A (zh) | 增强型志贺菌-肠产毒性大肠埃希菌多价疫苗 | |
| Levine | 3'TX F [IL Ec GR AD_ | |
| Konkel | In vitro analysis of the invasive properties of Campylobacter jejuni | |
| Candy | New enteric vaccines: application of new knowledge of receptors and recognition in enteric infections | |
| Edelman et al. | Summary of the 21st United States-Japan joint cholera conference | |
| Pickering et al. | Potential Effects of Immunization on the Host Defense Systems in Human Milk |